Warner Bros. Discovery, Inc.
LACTAM COMPOUND AS FXR RECEPTOR AGONIST
Last updated:
Abstract:
Disclosed is a compound as shown in formula (I), an optical isomer thereof or a pharmaceutically acceptable salt thereof, and the present invention relates to the use of same in the preparation of a drug for treating FXR-related diseases. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
25 May 2018
Issue date:
18 Jun 2020